Will Teladoc Reach $100? Teladoc Stock Forecast 2024-2030

Article Coverage: Latest TDOC performance, Teladac Stock Forecast 2024-2030, TDOC Analysts Price Target, Will Teladoc Reach $100?

TDOC Latest Price

Teladoc Stock Performance in the Last 12 Months

• Last 1 Month: -2.7%
• Last 6 Months: -22.4%
• Last 12 Months: -44.1%

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

TD0C is trading negatively on the 30-day candlestick chart. What are the signals and predictions?

TDOC has been trading within a narrow price range of $14 and $16 for the last couple of days. This has been a strong area of trade for the asset. The former has been a strong support while the latter is acting as a resistance. For TDOC, if it breaks above $16, the next target will be $20.

• Teladoc Stock Forecast Price Prediction in the next 24 hours is between $13.7 and $13.7
• Teladoc Stock Forecast Price Prediction this week is between $13.7 and $13.7

Will Teladoc Reach $100?

Teladoc has the potential to reach $100. However, for TDOC to be $100 from its current price, it will have to rise 7 times. At $100, the market cap of Teladoc will likely be $16.7 billion. In terms of years, if TDAC gains 25% annually, it will take around 9 years for it to reach $100.

• Quality of Investment– Good
• Time and Growth required to reach $100– Feasible
• Market Cap at $100– Feasible

Considering the criteria Quality of Investment, growth required, and time required, TDAC has a good chance of reaching $100.

Teladoc Stock Forecast: 12-Month Price Target

Average Price Target	$18.6
Truist Securities	$17
Cantor Fitzgerald	$22
Leerink Partners	$17
DA Davidson	$18
Citigroup	$19

Teladoc Stock Forecast 2024-2030

• Teladoc Stock Forecast Price Prediction 2024 is $17.1
• Teladoc Stock Forecast Price Prediction 2025 is $21.6
• Teladoc Stock Forecast Price Prediction 2026 is $27.1
• Teladoc Stock Forecast Price Prediction 2027 is $34.1
• Teladoc Stock Forecast Price Prediction 2028 is $42.9
• Teladoc Stock Forecast Price Prediction 2029 is $53.8
• Teladoc Stock Forecast Price Prediction 2030 is $67.5

Teladoc TDOC Stock Forecast: Macros

The healthcare sector is going through a paradigm shift in the post-COVID era. The ever-increasing use of technology in all sectors including health care has been witnessed lately. Moreover, there has been a transformation from an emphasis on quantity to quality. For instance, earlier doctors were paid according to the number of tests they perform, the number of patients they treat, and other fee-based incentives. But now the healthcare sector will be valued and they will be paid according to favorable patient treatments, thereby increasing the quality of treatments given to patients overall.

The number of collaborations is also on the rise. Instead of opening their healthcare centers, doctors of late prefer working in hospitals instead. This centralization of health care has helped in increasing the quality of service offered. In a nutshell, the sector is witnessing a favorable shift from focusing on the bottom line to focusing on patients.

TDOC stock forecast: Bear Case

• Disastrous Livongo Acquisition-  Teladoc Health acquired Livongo Health- which specialized in chronic care management in 2020 for $18.5 billion. But the fortunes of Livongo changed after its acquisition. The company which was doing so well before the acquisition could not add value to Teladoc Health and in fact, chronic care membership had slowed down to such levels that Teladoc had to pay $6.6 billion goodwill impairment charges in this quarter related to the Livongo acquisition. Goodwill is the amount that a company pays for a particular asset beyond its real value and recent impairment charges paid signal that Teladoc paid way too much for Livongo and it is not worthy enough. Recent impairment charges have led to a 50% decrease in Teladoc’s goodwill. All this shows that the Livongo acquisition was a disastrous one.   

• BetterHelp Not Performing Well –Another headwind for Teladoc is that its star product BetterHelp- its mental health segment is not performing well for a year now. In this space, the company is losing market share to well-funded competitors that keep flocking to the market, for example, Talkspace (TALK) is another competitor for BetterHelp eating up its market share. Also, management cited low rewards for marketing campaigns for BetterHelp and increased costs leading to a decrease in the revenue guidance for coming quarters.

• Management is not up to the Mark – It is true that the acquisition of Livongo Health has gone poorly for Teladoc and also its lowered guidance helped the investors to press the sell button. But there is a larger picture as to why Teladoc is performing poorly and that has to do with the approach of management. It has been the case that management has been telling one thing to investors and results are depicting something else. They are not able to deliver what they promise investors. This makes it difficult to trust the management.

TDOC Stock Forecast 2024: Bull Case

• Possibility of a turnaround after a 90% fall – Teladoc is down by 76% in the last year (as of 14.05.2022) and is down by almost 90% from its all-time high of $154. The optimism is due to comments by Ark Invest CEO Cathie Wood who even compared Teladoc with Amazon’s decline and said that both the stocks belong to the “same league”. Noticeably, Wood’s ETF owns nearly 11% of Teladoc and it was an attempt to stabilize the share price. Also, the stock is looking cheap right now and is trading at only 2.1 times the forward sales estimate with a possibility of a turnaround anytime soon.

• Bright spots from recent quarter results- Let’s dissect the recent quarter results and find out the bright spots from the same. The fuzz is all about goodwill impairment charges and lowered guidance. But keeping that aside, results do match the expectations.

Will Teledoc Reach $100: Conclusion

Teladoc is the leader in its space and it has been growing at a very good pace of 20% quarterly and annually. It can be argued that management has lowered guidance, but it is always good to project less and perform better, it may happen that in the next quarter’s results, it beats estimates handsomely and the share price goes up by 40% on the eve of results.

That said, it is also true that Teladoc is facing its own share of problems and it messed up the acquisition of Livongo and has lowered guidance for the fiscal year in a panic. Also, BetterHelp needs to deliver to enable Teladoc to come out of the woods. Livongo features are still not fully integrated with the Teladoc app and it can be a winner in the coming years if used properly.

Investment in Teladoc at this juncture depends on the risk appetite of investors. While it presents a golden opportunity to have multi-bagger returns in a couple of years, it is a risky bet and there are more hurdles ahead for management to come back on track.

Read our other stock forecasts here

Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions.